Literature DB >> 15177187

A role for ezrin in a neglected metastatic tumor function.

Stefano Fais1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15177187     DOI： 10.1016/j.molmed.2004.04.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


× No keyword cloud information.
  12 in total

1.  Increase in ezrin expression from benign to malignant breast tumours.

Authors:  Daphne Gschwantler-Kaulich; Camilla Natter; Stefan Steurer; Ingrid Walter; Almut Thomas; Mohamed Salama; Christian F Singer
Journal:  Cell Oncol (Dordr)       Date:  2013-10-16       Impact factor: 6.730

Review 2.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

Review 3.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

Review 4.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

5.  High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy.

Authors:  Hong-Jian Wang; Jin-Shui Zhu; Qiang Zhang; Qun Sun; Hua Guo
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

6.  A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates Rac1 and controls neurite growth.

Authors:  Wenjing Ruan; Christopher T Lee; Julie Desbarats
Journal:  Mol Biol Cell       Date:  2008-05-28       Impact factor: 4.138

7.  Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.

Authors:  Takuro Kobori; Mayuka Tameishi; Chihiro Tanaka; Yoko Urashima; Tokio Obata
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

8.  Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ.

Authors:  Sébastien N Voisin; Olga Krakovska; Ajay Matta; Leroi V DeSouza; Alexander D Romaschin; Terence J Colgan; K W Michael Siu
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

9.  Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration.

Authors:  K Endo; S Kondo; J Shackleford; T Horikawa; N Kitagawa; T Yoshizaki; M Furukawa; Y Zen; J S Pagano
Journal:  Oncogene       Date:  2009-02-23       Impact factor: 9.867

10.  Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.

Authors:  Jingchun Jin; Tiefeng Jin; Meiling Quan; Yingshi Piao; Zhenhua Lin
Journal:  Diagn Pathol       Date:  2012-10-05       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.